BridgeMD
New treatment option for Primary Progressive Aphasia
Official title A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931
ClinicalTrials.gov ID: NCT05730023
What this study is testing
- What it's testing
- Primary Progressive Aphasia (PPA) is a syndrome due to different neurodegenerative disorders selectively disrupting language functions. PPA specialist care is underdeveloped.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Diagnosis PPA according to the current clinical criteria (Gorno-Tempini et al., 2011);
- Mild PPA defined using the Progressive Aphasia Severity Scale (PASS);
- Italian native speakers.
You likely can't join if
- Presence of developmental disorders;
- Presence of any medical or psychiatric illness that could interfere in completing assessments;
- Presence of any medical condition that represents a contraindication to tDCS.
The study team makes the final eligibility decision.
Where it's taking place
- Brescia, BS, Italy
- Milan, MI, Italy
- Pavia, PV, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brescia, BS, Italy; Milan, MI, Italy; Pavia, PV, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.